Aehr Stock Soars 22%, Adding $363 Million, After Raising 2027 Revenue Outlook To $150 Million

The chip-testing company swung to a quarterly profit and lifted its fiscal 2027 revenue outlook after record sales.

Share
Aehr Stock Soars 22%, Adding $363 Million, After Raising 2027 Revenue Outlook To $150 Million

Aehr Test Systems, which makes equipment that tests and burns in semiconductor chips, soared 21.60% to $62.59 in Tuesday trading as of 10:01 a.m. ET, adding $363 million in market value, after it said Monday that record quarterly sales and a $109.3 million backlog support a higher full-year outlook.

Outlook raised, sales triple

The company said in an 8-K filed Monday that it now expects fiscal 2027 revenue of $150 million, up from a prior range of $130 million to $150 million.

Quarterly sales tripled to a record $33.0 million, and Aehr posted a $7.2 million profit. New orders totaled $46.7 million, lifting the order cushion to $109.3 million as of November 1.

The stock was on pace for its biggest one-day gain since July 21, when it rose 27.9%.

A burn-in specialist's wild year

Burn-in runs chips under heat and electrical stress to catch early failures. Aehr sells wafer-level systems, the FOX family, and package-level systems, the Sonoma, Tahoe and Echo lines. Customers include chipmakers, contract assemblers and test service companies.

The shares entered the session after a 52% fall over the previous month, sitting 65% below their highest close of the past year, set on Aug. 17. They were still up about 155% year to date as of Monday's close, well ahead of the S&P 500's roughly 10% gain.

In its most recent fiscal-year annual report, Aehr showed revenue of $18.8 million in its latest quarter, up 33.7% from a year earlier. The five largest customers made up about 70% of fiscal 2026 net revenues.

Taiwan test cell and AI customer

In August, Aehr announced a $22 million follow-on order from its lead AI processor production customer, which the company cites as support for that customer's continued burn-in capacity expansion.

Aehr's CEO said a pending test cell is expected to be installed in Taiwan in early calendar 2027, with a broader production decision to follow months later.

The Taiwan test cell, expected in early calendar 2027, is the next milestone the CEO named.

Sources

More on Aehr Test Systems

All Aehr Test Systems (AEHR) coverage →